如何治疗亚综合征焦虑症--在初级保健中实施的实用建议。

Daniel Lucas da Conceição Costa, Rodolfo Furlan Damiano, José Ángel Alcalá, Martin Hatzinger, Francisco Mesa, Giampaolo Perna, György Purebl, Péter Torzsa, Věra Vobořilová, Peter Zwanzger, Roger Ho, Borwin Bandelow
{"title":"如何治疗亚综合征焦虑症--在初级保健中实施的实用建议。","authors":"Daniel Lucas da Conceição Costa, Rodolfo Furlan Damiano, José Ángel Alcalá, Martin Hatzinger, Francisco Mesa, Giampaolo Perna, György Purebl, Péter Torzsa, Věra Vobořilová, Peter Zwanzger, Roger Ho, Borwin Bandelow","doi":"10.1080/13651501.2024.2362131","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Anxiety is a common and disabling condition that significantly impacts quality of life. Subsyndromal anxiety (SSA) refers to anxiety symptoms that do not meet the full diagnostic criteria for an anxiety disorder but pose a risk for developing such disorders. We aimed to provide practical recommendations for the treatment of SSA in primary care settings.</p><p><strong>Methods: </strong>A narrative review was conducted to identify strategies for recognizing and treating patients with SSA.</p><p><strong>Results: </strong>The recommendations for treating SSA include lifestyle modifications such as exercise and stress reduction techniques, psychotherapy, and pharmacological treatments, including natural compounds like the lavender oil extract Silexan. Regular follow-up care is essential to monitor treatment response and address ongoing symptoms. Additionally, the use of the GAD-7 tool is recommended for accurately identifying patients with SSA.</p><p><strong>Conclusion: </strong>Implementing these recommendations in primary care can lead to effective treatment of SSA, preventing the development of more severe anxiety disorders. An integrative approach, combining lifestyle modifications, psychotherapy, and pharmacotherapy, including natural compounds, offers significant benefits for managing anxiety.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How to treat subsyndromal anxiety disorder - practical recommendations for implementation in primary care.\",\"authors\":\"Daniel Lucas da Conceição Costa, Rodolfo Furlan Damiano, José Ángel Alcalá, Martin Hatzinger, Francisco Mesa, Giampaolo Perna, György Purebl, Péter Torzsa, Věra Vobořilová, Peter Zwanzger, Roger Ho, Borwin Bandelow\",\"doi\":\"10.1080/13651501.2024.2362131\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Anxiety is a common and disabling condition that significantly impacts quality of life. Subsyndromal anxiety (SSA) refers to anxiety symptoms that do not meet the full diagnostic criteria for an anxiety disorder but pose a risk for developing such disorders. We aimed to provide practical recommendations for the treatment of SSA in primary care settings.</p><p><strong>Methods: </strong>A narrative review was conducted to identify strategies for recognizing and treating patients with SSA.</p><p><strong>Results: </strong>The recommendations for treating SSA include lifestyle modifications such as exercise and stress reduction techniques, psychotherapy, and pharmacological treatments, including natural compounds like the lavender oil extract Silexan. Regular follow-up care is essential to monitor treatment response and address ongoing symptoms. Additionally, the use of the GAD-7 tool is recommended for accurately identifying patients with SSA.</p><p><strong>Conclusion: </strong>Implementing these recommendations in primary care can lead to effective treatment of SSA, preventing the development of more severe anxiety disorders. An integrative approach, combining lifestyle modifications, psychotherapy, and pharmacotherapy, including natural compounds, offers significant benefits for managing anxiety.</p>\",\"PeriodicalId\":14351,\"journal\":{\"name\":\"International Journal of Psychiatry in Clinical Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-06-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Psychiatry in Clinical Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13651501.2024.2362131\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Psychiatry in Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13651501.2024.2362131","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

背景介绍焦虑症是一种常见的致残性疾病,严重影响人们的生活质量。亚焦虑症(SSA)是指焦虑症状不符合焦虑症的全部诊断标准,但有发展成焦虑症的风险。我们旨在为基层医疗机构治疗亚焦虑症提供实用建议:方法:我们进行了叙述性综述,以确定识别和治疗 SSA 患者的策略:治疗 SSA 的建议包括改变生活方式(如运动和减压技巧)、心理治疗和药物治疗,包括天然化合物(如薰衣草精油提取物 Silexan)。定期随访对于监测治疗反应和解决持续症状至关重要。此外,建议使用 GAD-7 工具来准确识别 SSA 患者:结论:在初级保健中实施这些建议可有效治疗 SSA,防止发展成更严重的焦虑症。将生活方式调整、心理治疗和药物治疗(包括天然化合物)结合起来的综合方法对控制焦虑症大有裨益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
How to treat subsyndromal anxiety disorder - practical recommendations for implementation in primary care.

Background: Anxiety is a common and disabling condition that significantly impacts quality of life. Subsyndromal anxiety (SSA) refers to anxiety symptoms that do not meet the full diagnostic criteria for an anxiety disorder but pose a risk for developing such disorders. We aimed to provide practical recommendations for the treatment of SSA in primary care settings.

Methods: A narrative review was conducted to identify strategies for recognizing and treating patients with SSA.

Results: The recommendations for treating SSA include lifestyle modifications such as exercise and stress reduction techniques, psychotherapy, and pharmacological treatments, including natural compounds like the lavender oil extract Silexan. Regular follow-up care is essential to monitor treatment response and address ongoing symptoms. Additionally, the use of the GAD-7 tool is recommended for accurately identifying patients with SSA.

Conclusion: Implementing these recommendations in primary care can lead to effective treatment of SSA, preventing the development of more severe anxiety disorders. An integrative approach, combining lifestyle modifications, psychotherapy, and pharmacotherapy, including natural compounds, offers significant benefits for managing anxiety.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.00
自引率
3.30%
发文量
42
审稿时长
>12 weeks
期刊介绍: International Journal of Psychiatry in Clinical Practice provides an international forum for communication among health professionals with clinical, academic and research interests in psychiatry. The journal gives particular emphasis to papers that integrate the findings of academic research into realities of clinical practice. Focus on the practical aspects of managing and treating patients. Essential reading for the busy psychiatrist, trainee and interested physician. Includes original research papers, comprehensive review articles and short communications. Key words: Psychiatry, Neuropsychopharmacology, Mental health, Neuropsychiatry, Clinical Neurophysiology, Psychophysiology, Psychotherapy, Addiction, Schizophrenia, Depression, Bipolar Disorders and Anxiety.
期刊最新文献
Mirtazapine blood levels and antidepressant response. Exploring real-world prescribing patterns for maintenance treatment in bipolar disorders: a focus on antidepressants and benzodiazepines. Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray. Real-world outcomes of long-term use of silexan in patients with anxiety disorders: a single-centre experience. Neurobiological and psychological factors to depression.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1